Malaria remains a major cause of morbidity and mortality throughout the world, with 32% of the world’s population living in areas of risk.1 Despite the progress that has been made in reducing the burden of malaria through improved access to preventive interventions,1 there remain many challenges to the eventual eradication of the parasite. Perhaps one of the greatest challenges is the continual battle with resistance, to both the drugs used to treat the cases and the insecticides used to kill the mosquito hosts.2, 3 The former problem is particularly acute in the Greater Mekong region in southeast Asia where resistance to the key drug—artemisinin—is now widespread……. continue reading

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30910-3/fulltext?elsca1=etoc

Advertisements